» Articles » PMID: 10075690

Inducible Degradation of IkappaBalpha by the Proteasome Requires Interaction with the F-box Protein H-betaTrCP

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 1999 Mar 13
PMID 10075690
Citations 40
Authors
Affiliations
Soon will be listed here.
Abstract

Activation of NF-kappaB transcription factors requires phosphorylation and ubiquitin-proteasome-dependent degradation of IkappaB proteins. We provide evidence that a human F-box protein, h-betaTrCP, a component of Skp1-Cullin-F-box protein (SCF) complexes, a new class of E3 ubiquitin ligases, is essential for inducible degradation of IkappaBalpha. betaTrCP associates with Ser32-Ser36 phosphorylated, but not with unmodified IkappaBalpha or Ser32-Ser36 phosphorylation-deficient mutants. Expression of a F-box-deleted betaTrCP inhibits IkappaBalpha degradation, promotes accumulation of phosphorylated Ser32-Ser36 IkappaBalpha, and prevents NF-kappaB-dependent transcription. Our findings indicate that betaTrCP is the adaptor protein required for IkappaBalpha recognition by the SCFbetaTrCP E3 complex that ubiquitinates IkappaBalpha and makes it a substrate for the proteasome.

Citing Articles

The multifunctional role of intrinsic disorder in NF-κB signaling.

Komives E Biochem Soc Trans. 2023; 51(6):2085-2092.

PMID: 38095058 PMC: 10754279. DOI: 10.1042/BST20230035.


Beta-Transducin Repeats-Containing Proteins as an Anticancer Target.

Kim D, Yi Y, Seong Y Cancers (Basel). 2023; 15(17).

PMID: 37686524 PMC: 10487276. DOI: 10.3390/cancers15174248.


Differential dysregulation of β-TrCP1 and -2 by HIV-1 Vpu leads to inhibition of canonical and non-canonical NF-κB pathways in infected cells.

Pickering S, Sumner J, Kerridge C, Perera M, Neil S mBio. 2023; 14(4):e0329322.

PMID: 37341489 PMC: 10470808. DOI: 10.1128/mbio.03293-22.


The KT Jeang Retrovirology prize 2022: Florence Margottin-Goguet.

Retrovirology. 2022; 19(1):20.

PMID: 36068604 PMC: 9446835. DOI: 10.1186/s12977-022-00606-3.


Structure activity relationship (SAR) study identifies a quinoxaline urea analog that modulates IKKβ phosphorylation for pancreatic cancer therapy.

Sagar S, Singh S, Mallareddy J, Sonawane Y, Napoleon J, Rana S Eur J Med Chem. 2021; 222:113579.

PMID: 34098465 PMC: 8373685. DOI: 10.1016/j.ejmech.2021.113579.